Targeting mTOR pathway: A new concept in cancer therapy
2010

Targeting the mTOR Pathway in Cancer Therapy

publication Evidence: moderate

Author Information

Author(s): S. H. Advani

Primary Institution: Jaslok Hospital and Research Centre

Hypothesis

The mTOR pathway is a crucial regulator of cell growth and proliferation, and its dysregulation plays a key role in various cancers.

Conclusion

mTOR inhibitors have shown promise in reducing tumor growth and may be effective across multiple cancer types.

Supporting Evidence

  • mTOR plays a central role in signaling caused by nutrients and growth factors.
  • mTOR regulates the production of proteins critical to cell metabolism and growth.
  • mTOR inhibitors have shown effectiveness in clinical studies for various cancers.

Takeaway

mTOR is like a traffic light for cells, telling them when to grow and when to stop. If it gets stuck on green, it can lead to cancer.

Methodology

The article reviews current knowledge and insights into mTOR biology and its role in cancer.

Limitations

The article does not provide specific clinical trial data or detailed statistical analyses.

Digital Object Identifier (DOI)

10.4103/0971-5851.76197

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication